Takeda America Offers $70 Million For IDM Pharma

Takeda America, a subsidiary of a Japanese drug company, offered to buy IDM Pharma Inc. (Nasdaq: IDMI) for about $70 million. The stock price leaped 91 cents to $2.61.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.